North America Kidney Cancer Therapeutics & Diagnostics Industry Overview
The North America Kidney Cancer Therapeutics & Diagnostics Market is moderately consolidated competitive. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. Some of the companies which are currently dominating the market are Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc, Abbott Laboratories, Amgen Inc, and Seattle Genetics.
North America Kidney Cancer Therapeutics & Diagnostics Market Leaders
-
Pfizer Inc
-
F. Hoffmann-La Roche Ltd
-
Bayer AG
-
Novartis AG
-
Amgen Inc
- *Disclaimer: Major Players sorted in no particular order
